Showing results (191-200 of 650) with videos related to
Sort By:
Pageof 65
Nature Cancer|September 28, 2020
eIF5B drives integrated stress response-dependent translation of PD-L1 in lung cancerShruthy Suresh, BeiBei Chen, Jingfei Zhu, et al.Nature Cancer|September 1, 2020
Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitorsPedram Razavi, Maura N Dickler, Payal D Shah, et al.Nature Cancer|October 30, 2020
Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemiaHaijiao Zhang, Yusuke Nakauchi, Thomas Köhnke, et al.Nature Cancer|December 17, 2021
Radiation-activated secretory proteins of Scgb1a1+ club cells increase the efficacy of immune checkpoint blockade in lung cancerYi Ban, Geoffrey J Markowitz, Yue Zou, et al.Nature Cancer|November 5, 2021
Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate CancerYuanyuan Qiao, Jae Eun Choi, Jean C Tien, et al.Nature Cancer|December 6, 2021
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanismsJanne Lehtiö, Taner Arslan, Ioannis Siavelis, et al.Nature Cancer|December 23, 2021
Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatmentCatherine Gutierrez, Aziz M Al'Khafaji, Eric Brenner, et al.Nature Cancer|September 22, 2022
METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinomaXiangyu Zeng, Fei Zhao, Gaofeng Cui, et al.Nature Cancer|September 6, 2022
Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistanceSu Deng, Choushi Wang, Yunguan Wang, et al.Nature Cancer|August 29, 2022
Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancerRami S Vanguri, Jia Luo, Andrew T Aukerman, et al.Pageof 65